acut
otiti
media
gener
regard
bacteri
infect
howev
mani
studi
past
decad
shown
close
associ
acut
otiti
media
respiratori
viral
infect
associ
demonstr
tempor
coincid
viral
epidem
peak
incid
acut
otiti
media
epidemiolog
studi
henderson
et
al
well
document
viral
infect
acut
otiti
media
patient
chonmaitre
et
al
heikkinen
et
al
alreadi
evid
studi
exploit
convent
techniqu
ie
isol
virus
nasal
aspir
middl
ear
fluid
sampl
use
serolog
chonmaitre
et
al
harsten
et
al
develop
new
simpler
often
sensit
laboratori
method
viru
detect
antigen
assay
polymeras
chain
reaction
pcr
assay
contribut
accumul
evid
associ
ranta
et
al
heikkinen
et
al
convinc
evid
base
viru
specif
intervent
studi
proport
acut
otiti
media
occur
influenza
outbreak
prevent
immun
children
influenza
viru
vaccin
heikkinen
et
al
modern
diagnost
method
human
rhinoviru
group
rsv
found
common
respiratori
virus
associ
acut
otiti
media
young
children
arola
et
al
ranta
et
al
vesa
et
al
human
rhino
entero
parechovirus
rna
virus
belong
picornavirida
famili
rhinovirus
assum
caus
mostli
mild
upper
respiratori
infect
although
sever
diseas
pneumonia
also
document
elsahli
et
al
human
enterovirus
clinic
express
infect
rang
sever
paralysi
minor
febril
ill
chonmaitre
mann
enterovirus
found
viru
cultur
middl
ear
fluid
sampl
obtain
patient
acut
otiti
media
chonmaitre
et
al
heikkinen
et
al
cell
line
use
viral
cultur
vari
sensit
differ
enterovirus
enteroviru
serotyp
isol
standard
cell
cultur
use
diagnost
laboratori
pallansch
roo
introduct
revers
transcript
rt
pcr
method
made
possibl
studi
systemat
role
enterovirus
acut
otiti
media
children
parechovirus
previous
classifi
among
enterovirus
echoviru
serotyp
also
known
respiratori
pathogen
jokikorpela
two
finnish
studi
finnish
otiti
media
cohort
studi
vaccin
trial
larg
group
children
follow
close
occurr
acut
respiratori
infect
acut
otiti
media
month
age
total
period
year
virolog
result
cohort
studi
report
part
earlier
vesa
et
al
blomqvist
et
al
noksokoivisto
et
al
studi
present
virolog
find
studi
group
base
specimen
collect
acut
otiti
media
children
well
analysi
season
variat
specif
viru
occurr
cover
time
period
april
august
present
studi
includ
children
two
separ
cohort
first
studi
group
compris
healthi
children
enrol
finnish
otiti
media
cohort
studi
purpos
cohort
studi
assess
epidemiolog
risk
factor
acut
otiti
media
children
followup
period
month
age
april
juli
studi
design
present
detail
elsewher
et
al
vesa
et
al
studi
group
deriv
finnish
otiti
media
vaccin
trial
prospect
random
doubl
blind
cohort
studi
design
evalu
efficaci
safeti
two
sevenval
pneumococc
conjug
vaccin
studi
conduct
decemb
march
altogeth
children
enrol
studi
design
efficaci
result
conjug
vaccin
publish
elsewher
eskola
et
al
specimen
collect
sampl
children
subject
virolog
test
sampl
compris
subject
randomli
select
among
children
recruit
first
year
trial
whose
followup
time
decemb
septemb
differ
significantli
rest
children
regard
date
birth
sex
aspect
studi
children
enrol
follow
studi
clinic
establish
specif
purpos
tamper
region
finland
special
train
studi
doctor
nurs
clinic
studi
children
visit
clinic
enrol
month
age
thereaft
seven
nine
time
depend
studi
age
month
physic
examin
carri
interview
data
collect
schedul
visit
addit
famili
encourag
take
child
studi
clinic
whenev
symptom
acut
respiratori
infect
especi
acut
otiti
media
suspect
acut
otiti
media
diagnos
studi
doctor
myringotomi
perform
middl
ear
fluid
specimen
drawn
inflam
ear
electr
suction
apparatu
steril
collector
addit
nasopharyng
aspir
obtain
use
steril
pediatr
mucu
extractor
inform
written
consent
obtain
parent
studi
children
studi
protocol
consent
form
approv
ethic
committe
nation
public
health
institut
ethic
committe
tamper
health
center
tamper
univers
hospit
child
consid
acut
otiti
media
visual
abnorm
tympan
membran
regard
colour
posit
andor
mobil
suggest
presenc
middl
ear
fluid
togeth
least
one
follow
sign
symptom
acut
infect
fever
ear
ach
irrit
diarrhea
vomit
acut
otorrhea
caus
otiti
externa
simultan
respiratori
tract
symptom
karma
et
al
current
test
includ
acut
otiti
media
event
nasopharyng
aspir
sampl
least
one
middl
ear
fluid
sampl
avail
virolog
examin
evalu
acut
otiti
media
event
repres
acut
otiti
media
event
cohort
studi
vaccin
trial
viru
posit
acut
otiti
media
event
evalu
acut
otiti
media
event
viru
virus
detect
nasopharyng
aspir
middl
ear
fluid
specimen
cohort
studi
vaccin
trial
nasopharyng
aspir
middl
ear
fluid
specimen
frozen
immedi
collect
store
test
current
studi
specimen
collect
evalu
acut
otiti
media
event
occur
cohort
studi
correspond
specimen
deriv
sampl
children
vaccin
trial
subject
virolog
test
finnish
otiti
media
cohort
studi
rhinovirus
detect
combin
isolationrtpcr
method
report
previous
blomqvist
et
al
oneincub
timeresolv
fluoroimmunoassay
trfia
halonen
et
al
hierholz
et
al
hierholz
et
al
nikkari
et
al
use
detect
influenza
viru
b
parainfluenza
viru
type
rsv
adenoviru
specif
antigen
nasopharyng
aspir
middl
ear
fluid
sampl
cutoff
valu
posit
mean
neg
control
plu
six
time
standard
deviat
mean
finnish
otiti
media
vaccin
trial
nasopharyng
aspir
middl
ear
fluid
specimen
analyz
rhinoviru
enteroviru
parechoviru
rna
modif
rtpcrhybrid
method
describ
previous
blomqvist
et
al
rna
extract
ml
nasopharyng
aspir
middl
ear
fluid
use
commerci
kit
rneasi
qiagen
gmbh
heidelberg
germani
five
microlitr
rna
reversetranscrib
plate
stratagen
gmbh
heidelberg
germani
final
volum
ml
simultan
one
revers
primer
rhinoand
enterovirus
one
parechovirus
five
microlitr
cdna
subject
pcr
plate
two
revers
primer
two
biotinyl
forward
primer
one
rhinoand
enterovirus
one
parechovirus
primer
probe
rhinoand
enterovirus
publish
previous
blomqvist
et
al
noksokoivisto
et
al
parechovirus
primer
revers
forward
probe
aaccaatcctaa
three
prototyp
virus
human
rhinoviru
coxsackieviru
parechoviru
use
posit
control
step
sever
neg
control
includ
pcr
amplicon
identifi
micropl
hybrid
method
blomqvist
et
al
three
lanthanidelabel
probe
wallac
oy
turku
finland
whose
specif
test
known
prototyp
strain
rhinovirus
enterovirus
parechovirus
europiumlabel
rhinoviru
probe
detect
rhinoviru
prototyp
none
enterovirus
two
parechovirus
samariumlabel
enteroviru
probe
hybrid
enterovirus
rhinovirus
neither
parechovirus
five
rhinoviru
prototyp
human
rhinovirus
neg
rhinoviru
probe
posit
enteroviru
probe
one
rhinoviru
prototyp
type
neg
probe
terbiumlabel
parechoviru
probe
recogn
two
parechoviru
prototyp
none
rhinoor
enteroviru
prototyp
pcr
amplicon
test
three
differ
probe
time
three
parallel
well
plate
cutoff
valu
posit
specimen
ten
time
mean
neg
control
europiumlabel
probe
halonen
et
al
samariumand
terbiumlabel
probe
mean
neg
control
plu
five
time
standard
deviat
mean
modifi
heinonen
et
al
posit
result
least
two
three
parallel
well
requir
score
specimen
posit
specimen
regard
rhinoviru
posit
rhinoviru
probe
yield
posit
result
enteroviru
posit
enteroviru
probe
alon
posit
howev
aberr
reaction
rhinoviru
prototyp
enteroviru
group
may
includ
rhinovirus
nevertheless
simplic
virus
later
call
enterovirus
parechoviru
detect
parechoviru
probe
gave
posit
result
two
studi
altogeth
children
follow
examin
evid
viral
infect
time
diagnos
acut
otiti
media
studi
clinic
rate
acut
otiti
media
event
evalu
acut
otiti
media
event
similar
finnish
otiti
media
cohort
studi
vaccin
trial
gener
characterist
two
cohort
present
tabl
finnish
otiti
media
cohort
studi
total
children
experienc
evalu
acut
otiti
media
event
rang
altogeth
event
posit
least
one
viru
event
two
virus
found
viru
virus
identifi
nasopharyng
aspir
sampl
event
least
one
middl
ear
fluid
sampl
event
rhinoviru
detect
frequent
evalu
acut
otiti
media
event
rsv
detect
acut
otiti
media
event
influenza
viru
adenoviru
parainfluenza
viru
event
parainfluenza
viru
found
parainfluenza
viru
three
time
singl
sampl
posit
influenza
viru
b
rate
differ
viru
event
per
person
year
present
tabl
ii
enterovirus
parechovirus
search
vaccin
trial
finnish
otiti
media
vaccin
trial
children
studi
children
experienc
total
evalu
acut
otiti
media
event
rang
followup
nine
hundr
fifti
five
event
posit
least
one
viru
posit
two
three
virus
nasopharyng
aspir
sampl
viru
posit
event
one
middl
ear
fluid
sampl
event
picornavirus
found
associ
half
acut
otiti
media
event
rhinovirus
found
event
posit
result
obtain
enteroviru
probe
alon
event
parechovirus
seen
rare
rsv
found
acut
otiti
media
event
parainfluenza
viru
event
incid
virus
less
rate
differ
viru
event
per
person
year
shown
tabl
ii
finnish
otiti
media
cohort
studi
nasopharyng
aspir
middl
ear
fluid
specimen
collect
time
acut
otiti
media
avail
virolog
test
viru
posit
acut
otiti
media
event
event
nasopharyng
aspir
middl
ear
fluid
posit
viru
concurr
event
specif
viru
detect
concurr
specimen
type
tabl
iii
rsv
detect
concurr
type
sampl
rsv
posit
event
concurr
rhinovirus
influenza
viru
tabl
iii
noteworthi
event
rhinoviru
detect
middl
ear
fluid
yet
simultan
nasopharyng
aspir
finnish
otiti
media
vaccin
trial
nasopharyng
aspir
middl
ear
fluid
specimen
collect
time
acut
otiti
media
analyz
virus
nasopharyng
aspir
middl
ear
fluid
posit
viru
concurr
event
viru
posit
event
event
viru
detect
concurr
nasopharyng
aspir
sampl
least
one
middl
ear
fluid
specimen
tabl
iv
rsv
rhinoviru
found
concurr
nasopharyng
aspir
middl
ear
fluid
sampl
event
posit
rsv
rhinoviru
respect
enteroviru
probe
yield
concurr
posit
result
event
search
cohort
studi
tabl
iv
monthli
rate
acut
otiti
media
event
coincid
viral
infect
show
similar
season
variat
studi
fig
season
occurr
viru
posit
acut
otiti
media
event
follow
gener
incid
acut
otiti
media
event
highest
incid
rate
viru
neg
acut
otiti
media
event
seen
novemb
decemb
cohort
studi
vaccin
trial
winter
typic
peak
rhinoviru
epidem
seen
autumn
spring
studi
enterovirus
studi
vaccin
trial
present
year
includ
winter
spring
month
annual
rsv
epidem
also
seen
fig
influenza
virus
b
present
januari
march
parainfluenza
virus
mainli
detect
late
spring
adenovirus
present
almost
throughout
year
parechovirus
detect
septemb
march
two
larg
prospect
studi
shown
children
less
year
age
specif
respiratori
viru
present
nasopharynx
andor
middl
ear
fluid
two
third
acut
otiti
media
event
like
true
proport
acut
otiti
media
event
associ
viru
infect
even
higher
test
respiratori
virus
noksokoivisto
et
al
et
al
van
den
hoogen
et
al
antigen
detect
test
use
known
find
part
correspond
infect
ty
et
al
rhinovirus
detect
frequent
enterovirus
also
appear
major
group
among
respiratori
pathogen
two
viru
group
pcr
method
use
wherea
rsv
next
viru
order
detect
antigen
test
earlier
studi
suggest
rsv
one
import
virus
contribut
develop
acut
otiti
media
henderson
et
al
heikkinen
et
al
preval
differ
viru
group
two
studi
likewis
season
age
specif
occurr
rate
differ
virus
similar
studi
agreement
previou
preliminari
report
cohort
studi
base
nasopharyng
specimen
vesa
et
al
two
differ
detect
method
use
rtpcr
picornavirus
trfia
virus
pcr
method
gener
consid
sensit
detect
method
therefor
use
two
method
may
bias
rel
proport
number
refer
event
due
doubl
infect
event
may
occur
tabl
number
therefor
simpli
addit
row
entitl
n
give
number
event
given
viru
nasopharyng
aspir
column
entitl
n
give
number
event
given
viru
middl
ear
fluid
bold
number
indic
acut
otiti
media
event
viru
detect
concurr
nasopharyng
aspir
least
one
mef
sampl
event
categori
differ
virus
shown
pcr
method
might
sensit
antigen
detect
method
analysi
respiratori
virus
henkel
et
al
et
al
even
pcr
method
perfect
exampl
studi
primer
use
rtpcr
cover
differ
rhinoviru
strain
blomqvist
et
al
vari
epidemiolog
anoth
confound
factor
complic
comparison
result
differ
studi
unexpect
note
proport
acut
otiti
media
event
coincid
rhinoviru
infect
smaller
vaccin
trial
cohort
studi
even
though
combin
cellculturepcr
method
use
latter
studi
sensit
compar
direct
rtpcr
use
vaccin
trial
blomqvist
et
al
shown
recent
use
current
multiplex
rtpcr
method
either
rhinoviru
enteroviru
rna
nasopharyng
aspir
specimen
children
without
signific
concurr
respiratori
symptom
noksokoivisto
et
al
howev
children
presenc
viral
rna
nasopharynx
could
associ
recent
forthcom
symptomat
infect
exposur
infect
household
therefor
believ
great
major
virus
detect
acut
otiti
media
patient
involv
initi
respiratori
infect
observ
like
preval
viral
infect
would
even
greater
method
use
cover
potenti
caus
viru
group
strain
although
vaccin
trial
ten
differ
respiratori
virus
test
still
mani
known
probabl
also
unknown
virus
may
caus
respiratori
infect
children
coronavirus
influenza
c
virus
caus
upper
respiratori
infect
lesser
degre
age
group
noksokoivisto
et
al
et
al
previous
report
result
sampl
specimen
deriv
finom
cohort
studi
reveal
test
nasopharyng
aspir
specimen
collect
children
present
symptom
respiratori
infect
contain
human
coronaviru
rna
noksokoivisto
et
al
recent
discov
human
metapneumovirus
report
caus
children
respiratori
infect
clinic
resembl
rsv
infect
van
den
hoogen
et
al
finnish
otiti
media
cohort
studi
vaccin
trial
studi
season
preval
reveal
differ
winter
acut
otiti
media
event
associ
document
viral
infect
one
could
specul
diverg
reflect
epidem
caus
one
known
virus
includ
viru
detect
panel
epidem
due
unknown
viru
vaccin
trial
enterovirus
appear
associ
one
fourth
acut
otiti
media
event
studi
rhinoand
enteroviru
infect
identifi
first
amplifi
part
genom
use
primer
share
two
genera
subs
number
refer
event
due
doubl
tripl
infect
event
may
occur
tabl
number
therefor
simpli
addit
row
entitl
n
give
number
event
given
viru
npa
specimen
column
entitl
n
give
number
event
given
viru
mef
sampl
bold
number
indic
acut
otiti
media
event
viru
detect
concurr
npa
least
one
mef
event
categori
quentli
differenti
aid
viru
group
specif
probe
valid
analysi
method
show
enteroviru
probe
also
detect
rhinoviru
prototyp
although
sampl
interpret
posit
enteroviru
neg
rhinoviru
probe
sampl
may
contain
aberrantli
react
rhinovirus
convent
identif
enterovirus
viru
cultur
serotyp
neutral
antibodi
difficult
time
consum
better
method
desir
reliabl
differenti
enterovirus
rhinovirus
easi
identif
relev
serotyp
previous
specif
viral
diagnosi
upper
respiratori
infect
acut
otiti
media
littl
clinic
relev
howev
therapi
viru
infect
develop
rapidli
effici
drug
exist
virus
hayden
meissner
ison
et
al
pose
new
requir
viru
diagnost
new
opportun
treat
viral
infect
select
target
group
exampl
treatment
children
frequent
recur
infect
prevent
acut
otiti
media
specif
situat
might
feasibl
futur
conclus
present
virolog
find
associ
acut
otiti
media
children
less
year
age
two
larg
prospect
cohort
studi
respiratori
virus
present
two
third
acut
otiti
media
event
half
event
studi
picornaviru
infect
detect
use
pcrbase
method
detect
respiratori
virus
well
might
increas
overal
viru
detect
rate
studi
sampl
result
confirm
import
role
virus
develop
acut
otiti
media
futur
viru
group
associ
commonli
acut
otiti
fig
monthli
occurr
evalu
acut
otiti
media
event
occurr
acut
otiti
media
event
posit
viru
rhinovirus
enterovirus
rsv
finnish
otiti
media
cohort
studi
vaccin
trial
children
follow
month
age
media
ie
picornavirus
rsv
consid
aim
prevent
acut
otiti
media
children
